Synopsis
0
CEP/COS
0
JDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
Date of Issue : 2025-04-24
Valid Till : 2028-05-25
Written Confirmation Number : WC-0002
Address of the Firm : Plot No. A-2, A-2/1, A-2/2, UPSIDC Industrial Area, Bijnor Road, Gajraula -24423...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
US Patents
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
83
PharmaCompass offers a list of Migalastat API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Migalastat manufacturer or Migalastat supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Migalastat manufacturer or Migalastat supplier.
PharmaCompass also assists you with knowing the Migalastat API Price utilized in the formulation of products. Migalastat API Price is not always fixed or binding as the Migalastat Price is obtained through a variety of data sources. The Migalastat Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Migalastat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Migalastat, including repackagers and relabelers. The FDA regulates Migalastat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Migalastat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Migalastat manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Migalastat supplier is an individual or a company that provides Migalastat active pharmaceutical ingredient (API) or Migalastat finished formulations upon request. The Migalastat suppliers may include Migalastat API manufacturers, exporters, distributors and traders.
click here to find a list of Migalastat suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Migalastat DMF (Drug Master File) is a document detailing the whole manufacturing process of Migalastat active pharmaceutical ingredient (API) in detail. Different forms of Migalastat DMFs exist exist since differing nations have different regulations, such as Migalastat USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Migalastat DMF submitted to regulatory agencies in the US is known as a USDMF. Migalastat USDMF includes data on Migalastat's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Migalastat USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Migalastat suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Migalastat Drug Master File in Korea (Migalastat KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Migalastat. The MFDS reviews the Migalastat KDMF as part of the drug registration process and uses the information provided in the Migalastat KDMF to evaluate the safety and efficacy of the drug.
After submitting a Migalastat KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Migalastat API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Migalastat suppliers with KDMF on PharmaCompass.
A Migalastat written confirmation (Migalastat WC) is an official document issued by a regulatory agency to a Migalastat manufacturer, verifying that the manufacturing facility of a Migalastat active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Migalastat APIs or Migalastat finished pharmaceutical products to another nation, regulatory agencies frequently require a Migalastat WC (written confirmation) as part of the regulatory process.
click here to find a list of Migalastat suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Migalastat as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Migalastat API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Migalastat as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Migalastat and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Migalastat NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Migalastat suppliers with NDC on PharmaCompass.
Migalastat Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Migalastat GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Migalastat GMP manufacturer or Migalastat GMP API supplier for your needs.
A Migalastat CoA (Certificate of Analysis) is a formal document that attests to Migalastat's compliance with Migalastat specifications and serves as a tool for batch-level quality control.
Migalastat CoA mostly includes findings from lab analyses of a specific batch. For each Migalastat CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Migalastat may be tested according to a variety of international standards, such as European Pharmacopoeia (Migalastat EP), Migalastat JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Migalastat USP).
Comment (7)
